Retention of clinical biosamples / blank matrices [Regulatives / Guidelines]

posted by jag009  – NJ, 2019-04-23 17:22 (523 d 13:33 ago) – Posting: # 20211
Views: 1,785

Hi Ohlbe,

» Usually CROs keep the samples until the study report is approved by the sponsor. This makes sense, of course. Some sponsors will ask the CRO to keep the samples until the application is approved. Most CROs will charge for storage beyond a few months.

Do you know why some sponsors want to have their samples kept until application approved? From EMA or FDA, is there a requirement mentioned in any of the guidances? We are doing this (store samples) as well and I wonder why we need to if the age of the samples exceeds the long term stability date. I asked my folks and their answer was "we can always ask the CRO to extended the stability" :confused:

Thanks
J

Complete thread:

Activity
 Admin contact
21,080 posts in 4,397 threads, 1,468 registered users;
online 2 (0 registered, 2 guests [including 2 identified bots]).
Forum time: Monday 06:55 CEST (Europe/Vienna)

A central lesson of science is that to understand complex issues
(or even simple ones), we must try to free our minds of dogma and
to guarantee the freedom to publish, to contradict, and to experiment.
Arguments from authority are unacceptable.    Carl Sagan

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5